Kelly Blackburn
2015
In 2015, Kelly Blackburn earned a total compensation of $1.3M as Vice President, Clinical Affairs at aTYR PHARMA.
Compensation breakdown
| Non-Equity Incentive Plan | $78,770 |
|---|---|
| Option Awards | $882,090 |
| Salary | $295,000 |
| Other | $9,902 |
| Total | $1,265,762 |
Blackburn received $882.1K in option awards, accounting for 70% of the total pay in 2015.
Blackburn also received $78.8K in non-equity incentive plan, $295K in salary and $9.9K in other compensation.
Rankings
In 2015, Kelly Blackburn's compensation ranked 6,788th out of 13,638 executives tracked by ExecPay. In other words, Blackburn earned more than 50.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,788 out of 13,638 | 50th |
Division Manufacturing | 2,554 out of 5,190 | 51st |
Major group Chemicals And Allied Products | 918 out of 1,854 | 51st |
Industry group Drugs | 739 out of 1,528 | 52nd |
Industry Biological Products, Except Diagnostic Substances | 130 out of 254 | 49th |
Source: SEC filing on April 12, 2016.
Blackburn's colleagues
We found three more compensation records of executives who worked with Kelly Blackburn at aTYR PHARMA in 2015.